Cellular Health Screening Market Analysis, Size, Share and Forecast Report to 2028

San Francisco, California , USA, Sept 22, 2022 — /EPR Network/ —

Cellular Health Screening Industry Overview

The global cellular health screening market size was valued at USD 2.22 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028.

Cellular health screening facilitates easy and rapid understanding of one’s health at a cellular level. This technology helps in identifying areas that need immediate support and enables professionals to develop an individualized plan to achieve effective results. Due to the COVID-19 pandemic, market players witnessed a decline in their sales and base testing volume. Moreover, the supply chain is disrupted due to governmental impositions and restrictions on transportation, export, and import of products, raw materials, etc. during the pandemic. This has led to a decrease in the demand; many of the organizations have diversified their product portfolios from cellular health testing line to COVID-19 molecular and antibody testing, which can equally offset the decrease in base testing volume.

Applications of home-based diagnostic tests are significantly increasing globally. Public awareness campaigns aimed at identifying the symptoms of chronic diseases and ways to prevent them play an important role in controlling the spread of the disease. Thus, increased patient awareness has led to high demand for cellular health screening kits and services. The use of these devices also eliminates the need to wait for deciphering test results as well as aids in optimization of timely treatment decision, improves the efficacy of care provided, and significantly reduces diagnosis cost, especially in resource-constrained settings where laboratory infrastructure is weak.

Gather more insights about the market drivers, restrains and growth of the Global Cellular Health Screening market

Several research studies are indicative of the correlation between cancers and telomere length. Telomere shortening as a tumor suppressor proves to be a major factor in aggravated forms of cancer. Although it has been established that the length of telomeres is influenced by a variety of factors, such as infections, inflammation, and stress, these factors, particularly inflammation, resulting in oxidative stress, leading to telomere erosion.

Research supports telomere maintenance to being a major element for effects of environmental, lifestyle, and genetic issues on aging and related diseases. Therefore, the rate of telomere change facilitates a vital understanding of biological aging and genetic diseases. Furthermore, a decline of telomere length has been linked to age-related pathological issues, including Cardiovascular Diseases (CVDs), cancer, and reduced immune function. Thus, with the rising incidence of chronic diseases, the demand for cellular health screening is likely to increase in the coming years.

The rising number of programs by various organizations aimed at increasing awareness about preventive healthcare-based testing products and services will also augment market growth. Furthermore, collaborations, such as those undertaken by the CDC, National Cervical Cancer Coalition, the U.S. Preventive Services Task Force (USPSTF), WHO, and others, for cervical cancer screening are expected to boost the market growth during the forecast period. In addition, major market players are undertaking initiatives to increase awareness about cervical and vaginal cancer screening.

Browse through Grand View Research’s Clinical Diagnostics Industry Research Reports.

  • Polymerase Chain Reaction Market – The global polymerase chain reaction market size was valued at USD 37.36 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030.
  • Cardiac Biomarkers Market – The global cardiac biomarkers market size was valued at USD 13.98 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.7% from 2022 to 2030.

Cellular Health Screening Market Segmentation

Grand View Research has segmented the global cellular health screening market on the basis of test type, sample test, collection sites, and region:

Cellular Health Screening Test Type Outlook (Revenue, USD Million, 2016 – 2028)

  • Single Test Panels
  • Multi-test Panels

Cellular Health Screening Sample Test Outlook (Revenue, USD Million, 2016 – 2028)

  • Blood
  • Saliva
  • Serum
  • Urine

Cellular Health Screening Collection Sites Outlook (Revenue, USD Million, 2016 – 2028)

  • Home
  • Office
  • Hospital
  • Diagnostic Labs

Cellular Health Screening Regional Outlook (Revenue, USD Million, 2016 – 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies profiled:

Some prominent players in the global Cellular Health Screening market include

  • Telomere Diagnostics
  • SpectraCell Laboratories
  • Life Length
  • Repeat Diagnostics, Inc.
  • Cell Science Systems Corp.
  • Quest Diagnostics
  • LabCorp Holdings
  • OPKO
  • Genova Diagnostics
  • Immunodiagnostik AG
  • DNA Labs

Order a free sample PDF of the Cellular Health Screening Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Matched content

Editor’s pick

Express Press Release Distribution